BAKER BROS. ADVISORS LP

Position in ELVN — Enliven Therapeutics, Inc.

CIK 1263508 NEW YORK, NY

Position in ELVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,938,443

+$10,454,956 QoQ

Shares Held

905,191

0.0% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#22

of 210 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. ELVN ranks #35 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	30,762,330	$3,487,217,728
2	ONC	BeOne Medicines Ltd.	8,801,567	$2,508,182,547
3	RVMD	Revolution Medicines, Inc.	11,443,357	$2,143,111,898
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,143,131	$1,150,754,190
5	ACAD	Acadia Pharmaceuticals Inc	42,912,904	$1,085,696,471
6	KYMR	Kymera Therapeutics, Inc.	8,657,242	$992,725,940
7	INSM	INSMED Inc	8,796,111	$937,841,354
8	CELC	Celcuity Inc.	7,915,792	$828,150,159

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,938,443	905,191	0.0%	Shares	Sole	2026-08-14
2026-03-31	$35,483,487	905,191	+233.5%	Shares	Sole	2026-05-15
2025-12-31	$4,179,652	271,406	+136.3%	Shares	Sole	2026-02-17
2025-09-30	$2,350,631	114,833	0.0%	Shares	Sole	2025-11-14
2025-06-30	$2,303,549	114,833	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,259,913	114,833	0.0%	Shares	Sole	2025-05-15
2024-12-31	$2,583,742	114,833	0.0%	Shares	Sole	2025-02-14
2024-09-30	$2,932,834	114,833	0.0%	Shares	Sole	2024-11-14
2024-06-30	$2,683,647	114,833	0.0%	Shares	Sole	2024-08-14
2024-03-31	$2,019,912	114,833	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.